With support from the US Centers for Disease Control and Prevention, DC’s public health agencies and healthcare facilities will examine the occurrence of “superbugs” in a first-of-its-kind citywide evaluation.
University of Utah chemists have discovered a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
Early data suggests the test’s clinical potential for guiding anti-PD-1 therapy.
The Defense Health Agency has added 32 tests to its demonstration project reviewing tests not examined by FDA to determine whether they are safe and effective for use.
Launched in October, the program provides the essential first steps of a comprehensive approach to address the shortage of qualified laboratory professionals in the healthcare industry.
Qiagen developed GeneReader as a complete sample-to-insight next-generation sequencing solution, designed for any lab to deliver actionable results.
The biennial ASCP vacancy survey has captured a profession in transition.
Designed with cost-savings and functionality in mind, the company’s chemistry and reagent device permits all assay steps to be performed within a fully enclosed cartridge.
The closed-tube, scalable, 96-well based system from Luminex seeks to meet clinical demand for respiratory disease testing.
The fully automated Cobas 6800 and 8800 systems aim to introduce a new standard for routine molecular testing in the areas of viral load monitoring, donor screening, women’s health, and microbiology.
Under a new collaboration agreement, University of Colorado researchers will explore the utility of Sequenom’s liquid biopsy assay to determine whether ctDNA profiling can be used to monitor treatment response and relapse in melanoma patients.
In a partnership with Oxford University and the Oxford University Hospitals NHS Foundation Trust, Genomics plc will explore the translation of whole genome sequencing into clinical practice.
Affymetrix business unit eBioscience will sell Luminex’s multiplexed assay products in specified countries in the Americas, Asia, and Europe.
The Decipher genomic test for the prediction of cancer recurrence following prostate surgery and radiation was featured at the annual meeting of the American Society for Therapeutic Radiology and Oncology.
This month's Product News includes a high-throughput chemistry analyzer from Carolina Liquid Chemistries, a recombinant protein from BBI Solutions, and a creamatocrit analyzer from EKF Diagnostics.
The Precision Medicine Exchange Consortium seeks to facilitate data exchange, advance research, and support education and applications of precision medicine in oncology and molecular pathology.
University of Missouri study identifies more precise probability of cancer diagnosis.
Cedars-Sinai Medical Center has partnered with GenomeDx Biosciences on the Decipher genomics resource information database, a clinical genomics data-sharing program that unites physicians with GenomeDx’s full genome profiling platform.
Focused panel sets the groundwork for Illumina oncology program.
Developed by Focus Diagnostics, the test is cleared to identify 92 influenza and respiratory syncytial virus strains.